<DOC>
	<DOCNO>NCT01445223</DOCNO>
	<brief_summary>The present study aim compare efficacy , side-effects , treatment adherence three different treatment regimen give antiretroviral naïve HIV-1 infect patient . Treatment initiate accordance Swedish National Guidelines . In twice daily ( BID ) arm ( 1 ) , could consider standard regimen present , lopinavir/ritonavir , co-administrated 2 nucleoside reverse transcriptase inhibitor ( NRTIs ) administrate BID . The first daily ( QD ) arm ( 2 ) combine protease inhibitor ( PI ) atazanavir/ritonavir 2 NRTIs administrate QD , second QD arm ( 3 ) , non nucleoside reverse transcriptase inhibitor ( NNRTI ) efavirenz combine 2 NRTIs administrate QD . All drug use study license participate country patient follow clinical practice . Patients could optionally , informed consent , follow additional measurement HIV-1 RNA 1 , 2 , 3 week treatment asses kinetics viral decline initiation treatment .</brief_summary>
	<brief_title>A Study Antiretroviral Therapy ( ART ) Naïve Patients On Different Regimens Treat Hiv ( NORTHIV )</brief_title>
	<detailed_description />
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<criteria>Male female , age 16 year age HIV1 infect document licensed HIV1 antibody ELISA Ability understand provide inform consent Indication antiretroviral treatment Antiretroviral naïve All clinical laboratory value clinically significant Subjects pregnant Women childbearing potential practice birth control Subjects renal failure require dialysis Drug interaction study drug manageable Resistance study drug</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>HIV</keyword>
	<keyword>Antiretroviral therapy</keyword>
	<keyword>efavirenz</keyword>
	<keyword>lopinavir</keyword>
	<keyword>atazanavir</keyword>
	<keyword>randomise control clinical trial</keyword>
</DOC>